Physician Assistant in Enterprise, UT Accepting Medicare
2 Physician Assistant nurses found. Showing 1 - 2
 Karl Torgerson, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 223 S 200 E, Enterprise, UT 84725 Phone: 435-878-2281 |
Zachary Douglas Fisher, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 257 S 625 E, Enterprise, UT 84725 Phone: 435-669-6168 |
News Archive
Scientists explore relationship between moisture and disease establishment
Downy mildew is the biggest threat to spinach production around the world. While the pathogen has a short life cycle (approximately a week), it can produce millions of spores during the spinach growing season.
Blood levels of thyroid hormone may help identify individuals at risk for irregular heartbeat
Individuals with higher levels of thyroid hormone (free thyroxine, FT4) circulating in the blood were more likely than individuals with lower levels to develop irregular heartbeat, or atrial fibrillation, even when the levels were within normal range, according to new research in the American Heart Association's journal Circulation.
WFP, Syrian government work to address food insecurity, rising prices
"Hundreds of thousands of people are struggling to feed their families in the parts of Syria hardest hit by violence, activists and aid workers say, with access to food cut off by ruined infrastructure, rocketing prices and, say some, security forces who steal and spoil food supplies," the Washington Post reports.
Research shows brain cells move like a two-stroke engine
Following the often-quoted advice of Yogi Berra — "You can observe a lot by just watching" — Rockefeller University scientists show that nerve cells in the developing brains of humans and other mammals move in a two-part "step" led by a structure within the cell called the centrosome.
FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy
Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.
› Verified 8 days ago